Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MT1G |
| Upstream (Parents) |
|---|
| (<<) CBS → MT1G |
| (<<) CYP4F2 → MT1G |
| (<<) GPX3 → MT1G |
| (<<) HSD11B1 → MT1G |
| (<<) MT1F → MT1G |
| (<<) MT1P2 → MT1G |
| (<<) NNMT → MT1G |
| (<<) ORM1 → MT1G |
| (<<) RDH16 → MT1G |
| (<<) SAA4 → MT1G |
| Downstream (Children) |
|---|
| MT1G → AQP3 (>>) |
| MT1G → CXCL2 (>>) |
| MT1G → CYP1A1 (>>) |
| MT1G → DUSP10 (>>) |
| MT1G → GOT1 (>>) |
| MT1G → HSD17B2 (>>) |
| MT1G → HYAL1 (>>) |
| MT1G → MTSS1 (>>) |
| MT1G → PTGER4 (>>) |
| MT1G → RAB5B (>>) |
| MT1G → RASA1 (>>) |
| MT1G → ST3GAL6 (>>) |
